Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Bristol-Myers Squibb Company

NYSE: BMYHealthcare / Drug Manufacturers - Major / USA
49.13-0.5900-1.19%Vol 14 889 3921Y Perf -17.66%
Jan 16th, 2019 16:00
BID49.13 ASK49.14
Open49.65 Previous Close49.72
Pre-Market- After-Trading49.30
 - -%  0.17 0.35%
Target Price
60.63 
Analyst Rating
Moderate Buy 2.40
Potencial %
23.41 
Finscreener Ranking
★★     46.10
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
★+     43.49
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★★★     58.85
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
★★     43.40
Market Cap (mil)80 190 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
18.76 
Earnings Date
24th Jan 2019

Today's Price Range

49.1050.26

52wk Range

44.3070.05

5 Year PE Ratio Range

17.4082.90

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Month
-3.52%
3 Months
-16.59%
6 Months
-13.24%
1 Year
-17.66%
3 Years
-21.74%
5 Years
-5.43%

Quotes

Name / TickerPriceChg.Chg.%
BMY49.13-0.5900-1.19
AAPL154.941.87001.22
GOOG1 080.973.82000.35
MSFT105.380.37000.35
XOM71.64-0.0300-0.04
WFC48.941.27002.66
JNJ128.04-1.3200-1.02
FB147.54-1.4100-0.95
GE8.980.25002.86
JPM102.500.82000.81
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.30
Current Ratio
1.50
Long Term Debt to Total Capital
0.29
Total Debt to Equity
0.54
Interest Coverage
28.70
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
70.50
EBIT Margin
24.30
EBITDA Margin
27.30
Pre-tax Profit Margin
21.50
Profit Margin
23.88
ValuationValueIndustryS&P 500US Markets
PE Ratio
53.90
PB Ratio
5.74
PS Ratios
4.94
Price to Cash Flow
17.00
Price to Free Cash Flow
126.00
Cash Flow Per Share
2.82
Price to Tangible Book
13.40
Book Value per Share
8.36
Enterprise Value (in ths.)
78 819 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
15.86
ROE last 12 Months
10.08
Return on Assets (5Y Avg)
6.85
ROA last 12 Months
4.23
Return on Capital (5Y Avg)
9.60
ROC last 12 Months
7.10
Return on invested Capital Q
9.54
Return on invested Capital Y
4.90
Assets Turnover
0.20
Receivables Turnover
1.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
15 866 000
Revenue per Share
9.72
Revenue Growth 3 Years
6.07
Revenue Growth 5 Years
5.29
DividendsValueIndustryS&P 500US Markets
Dividend Yield
3.42
Dividend Rate
1.64
Dividend Growth 3 Years
1.19
Dividend Growth 5 Years
-2.90

Earnings HistoryEstimateReportedSurprise %
Q03 20180.911.0919.78
Q02 20180.871.0116.09
Q01 20180.850.9410.59
Q04 20170.670.681.49
Q03 20170.770.75-2.60
Q02 20170.730.741.37
Q01 20170.720.8416.67
Q04 20160.660.63-4.55
Earnings Per EndEstimateRevision %Trend
12/2018 QR0.843.70Positive
12/2018 FY3.886.59Positive
3/2019 QR1.033.00Positive
12/2019 FY4.093.81Positive
Next Report Date24th Jan 2019
Estimated EPS Next Report0.85
Estimates Count5
EPS Growth Next 5 Years %8.90
Volume Overview
Volume14 889 392
Shares Outstanding (in ths.)1 632 200
Trades Count56 796
Dollar Volume480 711 215
Avg. Volume26 385 865
Avg. Weekly Volume18 199 043
Avg. Monthly Volume18 402 951
Avg. Quarterly Volume12 808 910

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

68%32%

Bearish Bullish

47%53%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (30.00 %)
5 (45.45 %)
5 (41.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (70.00 %)
6 (54.55 %)
7 (58.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.40
Moderate Buy
2.09
Moderate Buy
2.17

There are no comments yet.

News